Insiders / Orbimed Advisors LLC / Activity
Activity — Orbimed Advisors LLC
19 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| May 28, 2026 | Buy | QTTB Q32 Bio Inc. Common Stock | $10.00M | +1.3M +55.48% | 3,502,987 11.77% of shares | high |
| Feb 10, 2025 | Buy | SION Sionna Therapeutics, Inc. Common Stock | $9.90M | +550K +17.43% | 3,704,959 8.19% of shares | high |
| Apr 21, 2026 | Buy | PRLD Prelude Therapeutics Incorporated Common Stock | $7.50M | +1.7M +16.69% | 11,808,945 14.80% of shares | high |
| May 28, 2026 | Buy | QTTB Q32 Bio Inc. Common Stock | $5.00M | +625K | 625,000 2.10% of shares | high |
| Apr 21, 2026 | Buy | PRLD Prelude Therapeutics Incorporated Common Stock | $5.00M | +1.1M | 1,126,126 1.41% of shares | high |
| Feb 18, 2025 | Buy | MBX MBX Biosciences, Inc. Common Stock | $1.02M | +94K +14.39% | 747,887 1.55% of shares | high |
| Apr 16, 2026 | Buy | TRAW Traws Pharma, Inc. Common Stock | $998.2K | +598K +98.71% | 1,203,250 7.94% of shares | high |
| Feb 18, 2025 | Buy | MBX MBX Biosciences, Inc. Common Stock | $531.9K | +49K +1.53% | 3,255,000 6.76% of shares | high |
| Feb 14, 2025 | Buy | MBX MBX Biosciences, Inc. Common Stock | $291.0K | +30K +0.93% | 3,205,930 6.66% of shares | medium |
| Feb 14, 2025 | Buy | MBX MBX Biosciences, Inc. Common Stock | $177.8K | +18K +0.57% | 3,176,390 6.60% of shares | medium |
| Dec 29, 2024 | Buy | TRAW Traws Pharma, Inc. Series A Warrant (right to buy) | — | +96K | 96,348 0.64% of shares | low |
| Dec 29, 2024 | Buy | TRAW Traws Pharma, Inc. Pre-Funded Warrant (right to buy) | — | +96K | 96,348 0.64% of shares | low |
| Jun 11, 2026 | Buy | STTK Shattuck Labs, Inc. Pre-Funded Warrants (right to buy) | — | +208K +4.09% | 5,303,908 5.28% of shares | low |
| Jun 11, 2026 | Buy | STTK Shattuck Labs, Inc. Pre-Funded Warrants (right to buy) | — | +1.0M +4.09% | 26,519,541 26.42% of shares | low |
| Apr 16, 2026 | Buy | TRAW Traws Pharma, Inc. Series C Warrants (right to buy) | — | +1.8M | 1,793,187 11.84% of shares | low |
| Apr 16, 2026 | Buy | TRAW Traws Pharma, Inc. Series B Warrants (right to buy) | — | +598K | 597,729 3.95% of shares | low |
| Apr 16, 2026 | Buy | TRAW Traws Pharma, Inc. Series A Warrants (right to buy) | — | +598K | 597,729 3.95% of shares | low |
| Apr 14, 2026 | Buy | IMA ImageneBio, Inc. Pre-Funded Warrants (right to buy) | — | +385K | 384,689 3.39% of shares | low |
| Apr 14, 2026 | Buy | IMA ImageneBio, Inc. Pre-Funded Warrants (right to buy) | — | +337K | 336,603 2.97% of shares | low |